Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

26%

6 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (4)
Early P 1 (2)
P 2 (2)
P 3 (3)
P 4 (3)

Trial Status

Completed6
Recruiting6
Unknown5
Not Yet Recruiting3
Withdrawn2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07671365Phase 4Not Yet Recruiting

Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)

NCT07658014Completed

Occult Vasoplegia in Normotensive Sepsis: Early Prediction With Diastolic Index and Lactate

NCT02965339WithdrawnPrimary

Evaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During Cardiac Surgery With Cardiopulmonary Bypass

NCT04964492CompletedPrimary

Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock

NCT04901169Phase 2Active Not Recruiting

Angiotensin II in Liver Transplantation

NCT05058612Phase 4RecruitingPrimary

Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)

NCT07345403Not Yet Recruiting

GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.

NCT06952907Not ApplicableRecruiting

Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients

NCT07125443Not ApplicableNot Yet Recruiting

Effect Inhaled Nitric Oxide in Adult Liver Transplant

NCT06615102Phase 3Recruiting

Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II

NCT05833828RecruitingPrimary

Differential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery

NCT06613256Recruiting

Characterisation of Endothelial Cells in Different Inflammatory Pathologies

NCT05922982Not ApplicableRecruitingPrimary

Norepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery

NCT04812717Not ApplicableUnknown

Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.

NCT05925348UnknownPrimary

Endotoxinemia and Vasoplegia Following Cardiothoracic Surgery With Cardiopulmonary Bypass (CPB)

NCT05199493Phase 3Completed

Reducing Acute Kidney Injury Occurence by Administering Angiotensin II

NCT05354193Completed

Analysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery

NCT03744702Early Phase 1CompletedPrimary

Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery

NCT03968926Unknown

Hypotension During Extracorporeal Circulatory Support Indicated for Cardiogenic Shock

NCT04301479Phase 3UnknownPrimary

Low Dose Corticosteroid Infusion in Vasoplegia After Cardiac Surgery (CORTIVAS-CS)

Scroll to load more

Research Network

Activity Timeline